An experimental antiviral medication can shorten the duration of colds and reduce the severity of cold symptoms, reported Frederick Hayden, MD. He presented a pooled analysis of data from two phase III trials of the drug at the 41st annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held recently in Chicago.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Investigational antiviral reduces duration, eases severity of viral respiratory infections

Newsletter